tetano
Editor, Senior Moderator
Br J Haematol
. 2020 Jul 11.
doi: 10.1111/bjh.16983. Online ahead of print.
Blood Cell Counts and Lymphocyte Subsets of Patients Admitted During the COVID-19 Pandemic: A Prospective Cohort Study
Paul J Hengeveld[SUP] 1 2 [/SUP], Aaram Omar Khader[SUP] 1 [/SUP], Linda H A de Bruin[SUP] 3 [/SUP], Inge G P Geelen[SUP] 1 [/SUP], Eske A van Baalen[SUP] 1 [/SUP], Eva Jansen[SUP] 1 [/SUP], Nathalie I Bouwer[SUP] 1 [/SUP], ?mer Balak[SUP] 4 [/SUP], Jurgen A Riedl[SUP] 3 [/SUP], Anton W Langerak[SUP] 2 [/SUP], Peter E Westerweel[SUP] 1 [/SUP], Mark-David Levin[SUP] 1 [/SUP]
Affiliations
Abstract
Aberrant blood cell counts, most prominently lymphopenia, have been identified as markers of the degree of severity of coronavirus disease 2019 (COVID-19) (Terpos et al, 2020; Yang et al, 2020; Wan et al, 2020; Wang et al, 2020; Zhao et al, 2020). However, most of these studies lack comparison to a COVID-19 negative, contemporary control group. Additionally, the longitudinal composition and dynamics of lymphocyte subsets in COVID-19 patients are insufficiently characterized.
Keywords: COVID-19; immunophenotyping; lymphocytes; lymphopenia; subsets.
. 2020 Jul 11.
doi: 10.1111/bjh.16983. Online ahead of print.
Blood Cell Counts and Lymphocyte Subsets of Patients Admitted During the COVID-19 Pandemic: A Prospective Cohort Study
Paul J Hengeveld[SUP] 1 2 [/SUP], Aaram Omar Khader[SUP] 1 [/SUP], Linda H A de Bruin[SUP] 3 [/SUP], Inge G P Geelen[SUP] 1 [/SUP], Eske A van Baalen[SUP] 1 [/SUP], Eva Jansen[SUP] 1 [/SUP], Nathalie I Bouwer[SUP] 1 [/SUP], ?mer Balak[SUP] 4 [/SUP], Jurgen A Riedl[SUP] 3 [/SUP], Anton W Langerak[SUP] 2 [/SUP], Peter E Westerweel[SUP] 1 [/SUP], Mark-David Levin[SUP] 1 [/SUP]
Affiliations
- PMID: 32652585
- DOI: 10.1111/bjh.16983
Abstract
Aberrant blood cell counts, most prominently lymphopenia, have been identified as markers of the degree of severity of coronavirus disease 2019 (COVID-19) (Terpos et al, 2020; Yang et al, 2020; Wan et al, 2020; Wang et al, 2020; Zhao et al, 2020). However, most of these studies lack comparison to a COVID-19 negative, contemporary control group. Additionally, the longitudinal composition and dynamics of lymphocyte subsets in COVID-19 patients are insufficiently characterized.
Keywords: COVID-19; immunophenotyping; lymphocytes; lymphopenia; subsets.